Xu Y - Search Results

1

[COVID-19 Vaccination for Cancer Patients: Progress and Preliminary Recommendations].

Wang L, Xu Y, Zhang L, Fan J, Pan R, Wang J, Wang M. Wang L, et al. Among authors: xu y. Zhongguo Fei Ai Za Zhi. 2021 Jun 20;24(6):377-383. doi: 10.3779/j.issn.1009-3419.2021.101.18. Epub 2021 May 24. Zhongguo Fei Ai Za Zhi. 2021. PMID: 34024060 Free PMC article. Review. Chinese.

2

[Progress in immunotherapy for non-small cell lung cancer].

Xu Y, Wang M. Xu Y, et al. Zhongguo Fei Ai Za Zhi. 2014 Jan;17(1):34-41. doi: 10.3779/j.issn.1009-3419.2014.01.06. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24398312 Free PMC article. Review. Chinese.

3

[Results of EGFR Mutations Detected in Pleural Effusion and Its  Clinical Significance in 132 Patients with Advanced Non-small Cell Lung Cancer:  A Retrospective Study in A Single Center].

Lu T, Li Q, Li L, Yang K, Zhou D, Gao J, Chen M, Xu Y, Zhong W, Wang M, Liang Z, Zhao J. Lu T, et al. Among authors: xu y. Zhongguo Fei Ai Za Zhi. 2020 Dec 20;23(12):1059-1065. doi: 10.3779/j.issn.1009-3419.2020.104.23. Zhongguo Fei Ai Za Zhi. 2020. PMID: 33357312 Free PMC article. Chinese.

4

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China.

Miao K, Zhang X, Wang H, Si X, Ni J, Zhong W, Zhao J, Xu Y, Chen M, Pan R, Wang M, Zhang L. Miao K, et al. Among authors: xu y. Front Oncol. 2022 Mar 15;12:859938. doi: 10.3389/fonc.2022.859938. eCollection 2022. Front Oncol. 2022. PMID: 35392244 Free PMC article.

5

Treating non-small cell lung cancer by targeting the PI3K signaling pathway.

Jiang L, Zhang J, Xu Y, Xu H, Wang M. Jiang L, et al. Among authors: xu h, xu y. Chin Med J (Engl). 2022 Jun 5;135(11):1272-1284. doi: 10.1097/CM9.0000000000002195. Chin Med J (Engl). 2022. PMID: 35830272 Free PMC article.

6

[Blocking Adenosine/A2AR Pathway for Cancer Therapy].

Liu J, Shi Y, Liu X, Zhang D, Bai Y, Xu Y, Wang M. Liu J, et al. Among authors: xu y. Zhongguo Fei Ai Za Zhi. 2022 Jul 20;25(7):460-467. doi: 10.3779/j.issn.1009-3419.2022.102.24. Zhongguo Fei Ai Za Zhi. 2022. PMID: 35899442 Free PMC article. Review. Chinese.

7

[Second-line chemotherapy and its survival analysis of 181 patients with extensive-stage small cell lung cancer in a single institute].

Ma M, Wang M, Xu Y, Hu K, Liu H, Li L, Zhong W, Zhang L, Zhao J, Wang H. Ma M, et al. Among authors: xu y. Zhongguo Fei Ai Za Zhi. 2013 Nov;16(11):572-8. doi: 10.3779/j.issn.1009-3419.2013.11.02. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24229622 Free PMC article. Chinese.

8

[Postoperative survival of patients with stage IIIa non-small cell lung cancer].

Liu H, Xu Y, Wang M, Hu K, Ma M, Zhong W, Zhang L, Zhao J, Li L, Wang H. Liu H, et al. Among authors: xu y. Zhongguo Fei Ai Za Zhi. 2013 Nov;16(11):596-602. doi: 10.3779/j.issn.1009-3419.2013.11.06. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24229626 Free PMC article. Chinese.

9

[Value of surgery for stage IIIa non-small cell lung cancer].

Liu H, Wang M, Hu K, Xu Y, Ma M, Zhong W, Zhao J, Li L, Wang H. Liu H, et al. Among authors: xu y. Zhongguo Fei Ai Za Zhi. 2013 Dec;16(12):639-45. doi: 10.3779/j.issn.1009-3419.2013.12.04. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24345488 Free PMC article. Chinese.

10

[First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].

Ma M, Wang M, Xu Y, Hu K, Liu H, Li L, Zhong W, Zhang L, Zhao J, Wang H. Ma M, et al. Among authors: xu y. Zhongguo Fei Ai Za Zhi. 2014 Jan;17(1):8-14. doi: 10.3779/j.issn.1009-3419.2014.01.02. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24398308 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,168 results

Search Page